Antibiotics are one of the greatest triumphs in the history of medical science—but these lifesaving tools have a dark side.

A new tool—seen as the Google Earth for genomics—will transform how scientists visualize and analyze genomic data, advancing ...

Advances in the speed, scale, and affordability of nucleic acid synthesis over the last two decades have catalyzed a rapidly evolving landscape in ...

To make advances in using microbes to sustainably produce materials, it is necessary to find new molecular tools, or ...

We were trying to learn how certain animals lost their regeneration capacity during evolution and then put back the ...

In a bold move to redefine the future of human performance and wellbeing, MAXIOM Labs and DNAthlete AG today announced a strategic partnership to combine ...

Ludhiana chapter, in association with the Indian Society for the Advancement of Insect Science (INSAIS), Ludhiana, organised ...

The global Proteinase K Market is estimated to be valued at USD 4,684.2 million in 2025 and is projected to reach USD 9,128.8 million by 2035, registering a compound annual growth rate (CAGR) of 6.9% ...

Within roughly five years, the pair succeeded in combining Cohen’s plasmids and Boyer’s enzymes to create recombinant DNA technology, genetically engineering bacteria that could produce a foreign ...

A new study in the peer-reviewed journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are encapsulated into recombinant adeno-associated virus ...

The Recombinant DNA Technology Market size is expected to be worth around USD 1288.5 Bn by 2032 from USD 786.7 Bn in 2023, growing at a CAGR of 5.8% during the forecast period from 2023 to 2032.

Recombinant ones are monoclonal, and here are the key steps involved in their production. Recombinant antibody production involves the use of recombinant DNA technology to produce an antibody.